Client Overview
The client’s program involved an antibody-conjugate USDMF, which required an FDA Information Request response. The engagement focused on reviewing source content, identifying gaps, and submitting a complete response within Regulatory timelines.
Background
The client needed a strong response to an agency information request connected to DMF content. This required document evaluation, rapid gap identification, and efficient coordination among stakeholders to avoid delays and preserve compliance.
Services in Scope
Compilation and evaluation of the IR response package.
Review of documents and relevant submission materials before filing.
Final submission of the response to the US FDA.
Support to maintain compliance and continuity in the US market.
Challenges
Stringent deadlines for preparing the response package.
Need to identify gaps in documents received from the client.
Requirement to collaborate quickly with multiple stakeholders to improve turnaround time.
Solution
Freyr used a response-focused review model that emphasized document gap assessment, rapid coordination, and thorough evaluation of the relevant submission materials. This allowed the client to address the agency’s request in a controlled manner while protecting compliance and continuity.
1
Reviewed the documents received from the client to identify deficiencies and missing elements.
2
Evaluated the relevant submission material thoroughly to support a strong IR response package.
3
Coordinated with stakeholders to accelerate turnaround and finalize response content.
4
Submitted the completed response to the US FDA within the required timeline.
Impact
- Achieved successful compilation, evaluation, and submission of the IR response.
- Helped the client uphold product compliance and continuity in the US market.
- Improved response quality under tight timelines through structured review and coordination.
Concluding Remarks
Freyr transformed the client's high-pressure agency request into a disciplined, timely response. The engagement enhanced document quality, sped up stakeholder alignment, and maintained FDA compliance. This model is especially useful for complex programs with DMF-related information requests that can strain operations.
